Testing a new nasal spray for seasonal allergies
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new nasal spray (ALDP001) in adults with seasonal allergies to ragweed. It aims to find the best dose and how often to use it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had seasonal allergy symptoms (like sneezing, runny nose, itchy eyes) for at least a few months each year for more than 1 year, and your symptoms are not due to other causes like infections.
- You had a positive skin prick test for ragweed pollen in the last 12 months (where the test area swells at least as big as a pea).
- You are in generally good health, as determined by a doctor based on your medical history and routine tests.
- You do not have any nose problems like nasal polyps, a hole in the septum, or chronic sinusitis.
- You do not have a history of frequent nosebleeds or a condition called rhinitis medicamentosa (nasal spray overuse).
- You do not have current or long-term liver disease, and your heart rhythm test (ECG) shows a normal QT interval.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether PL-14, a new nasal spray, works better than saline spray at relieving seasonal allergy symptoms like sneezing, itching, and congestion. If it works well and is safe, it could offer patients a new way to manage allergies during pollen season.
This trial tests a new biologic medicine (injection) to see if it can better control seasonal allergy symptoms in teens who haven't had good relief from standard treatments like nasal sprays.
This study tests a new nasal spray (PG-011) for adults with moderate-to-severe seasonal allergies (hay fever). It compares the spray to a placebo to see if it reduces nasal symptoms like stuffiness, sneezing, and runny nose.
This trial tests a new nasal spray for people with perennial (year-round) allergic rhinitis. It aims to see if the medicine works well and is safe compared to other treatments.
This trial tests a new drug called AK139 for people with seasonal allergies (hay fever) that are not well controlled by standard treatments like nasal sprays. It aims to see if the drug can improve symptoms during pollen season.
This trial tests a new injection called SHR-1819 for people with seasonal allergies who haven't responded well to standard treatments like nasal sprays or antihistamines. It aims to see if it can reduce allergy symptoms.
Hear when a new Seasonal Allergic Rhinitis (SAR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.